INTRODUCTION
Scrotal ultrasound increased detection of small and not palpable testicular lesions. The incidence of benign tumors is clinically relevant in lesions smaller than 15 mm (1, 2) . This suggest organ-sparing surgery rather than radical orchiectomy (3, 4) . The first step to diagnose testicular cancer is the clinical examination, principally with scrotal palpation, that can give to the physician the first suspect of tumor. But it is possible only for masses which have a large volume. Consequently patients must undergo scrotal ultrasound, that confirms the presence of the neoplasia. The definitive histologic diagnosis of testicular cancer can only be achieved through exploration and inguinal orchiectomy and subsequent histological examination (5) . In fact, the gold standard for the treatment of palpable testicular lesions is inguinal exploration and orchiectomy. Meanwhile, the diagnostic-therapeutic pathway for small and not palpable small testicular lesions exclusively identified by ultrasonography is still under debate. According to international guidelines testis-sparing surgery can be performed only in special and selected cases: bilateral testicular tumors (synchronous bilateral testicular tumors or metachronous contralateral tumors) or monorchid patient with normal pre-operative testosterone levels when tumor volume is less than 30% of testicular volume (2) (3) (4) . For some years the testis sparing surgery is being practiced with success, with good oncologic out-comes, but there is not currently internationally agreed protocol for management and treatment of small non-palpable testicular masses. Our team published a flow chart including ultrasound diagnosis and surgical management of lesion with maximum diameter of 15 mm (6) . This protocol was established with agreement of pathology, radiology, urology and oncology units. However application of this clinical protocol is not yet published. Primary aim of this study was to perform radical surgery in all malignant tumor. Secondary aim was to verify the efficacy of the diagnostic-therapeutic pathway recently adopted in management of small masses with testis sparing surgery only in benign lesions.
MATERIALS AND METHODS
In this multicenter study, we recruited patients with single testicular lesion of 15 mm as main diameter, based on scrotal ultrasound. We applied the diagnostic-therapeutic pathway described by Sbrollini et al. (6) which comprises: 1) normal testicular tumor markers, 2) repeated scrotal ultrasound at the tertiary center to confirm size, localization and ultrasound characteristics, 3) surgical exploration with inguinal approach using intraoperative ultrasound, and intraoperative pathological examination. The diagnostic-therapeutic pathway recently adopted in management of small masses with testis sparing surgery is summarized in Figure 1 . Definitive histology was reviewed by a dedicated uro-pathologist. After their identification, the nodule was removed and 3 additional biopsies were perfomed in surround normal-looking parenchyma. If the pathologist considered the nodule size with enough amount of tissue, the intraoperative frozen was done, otherwise if not the specimen was sent for definitive histology. In case of benign or doubtful histology on frozen section, the specimen were submitted to definitive exam. Delayed orchiectomy was suggested only if malignant neoplasia was confirmed. In case of testicular intraepithelial neoplasia, patients were addressed to radiotherapy or orchyfuniculectomy. The protocol suggests that small masses (< 8 mm) are sent to the pathologist for histological definitive examination, avoiding the extemporaneous examination, which due to the small volume of the tumor, might subtract material necessary for definitive histological diagnosis. The masses of diameter between 8 and 15 mm are sent to the pathologist for the extemporaneous histological examination of frozen sections, which determines: histological nature, size and relationship with the surrounding pa renchyma. All testicular masses were submitted to definitive histological examination including immunohistochemistry.
RESULTS
We recruited 28 patients, mean age was 38 years (18-68) and mean lesion size was 9.3 mm (range 2.5-15). Baseline clinical features are summarized in Table 1 and 2. Oncological testicular markers were normal except in a case who had small increase beta-HCG (9.0). Intraoperative ultrasound was necessary in 8/28 cases to identify the exact cancer location. In particular, 10/28 (36%) patients had testicular nodules smaller than 8 mm and 18/28 (64%) between 8 and 15 mm (Figure 3-6 ). Concerning nodules smaller than 8 mm, 2/10 underwent definitive histological examination (because of low volume of the sample). Primary aim of this study was to perform radical surgery in malignant tumor. We performed 11 (Table 2 ).
DISCUSSION
Our study has shown the reliability of the diagnostic-therapeutic pathway suggested by Sbrollini et al. in the management of single testicular masses below 15 mm. The higher incidence of benign lesions in this group of tumors (60%) makes often orchiectomy an overtreatment. We observed a complete concordance between frozen section examination and definitive histology regarding malignant cell. Previous experience in high volume centers had same results with dedicated pathologist (7, 8) , pointing out that in our center there was always a dedicated uro-pathologist too. In our experience the definitive intraoperative diagnosis of non-palpable testicular lesions was always reliable even in very small lesions (< 8 mm). However in case of uncertain diagnosis or small tissue, the definitive histology is recommended. This protocol is useful also for centres were the frozen section is not available: very small lesions could be managed with definitive histology and any subsequent decision can be delayed. In our experience, intraoperative histology on frozen section was possible in 8 of 10 small nodules with diameter less than 8 mm, Testis sparing surgery is adopted also in selected cases in children (9) . During surgery the surgeon should use loop for optical magnification and use palpation to detect the nodule. In case of soft nodule, were the palpation is not helpful, the intraoperative ultrasound is mandatory. This protocol should be shared in the first instance by the involved specialists, such as the urologist, as an active operator in the operating room, the pathologist, the oncologist and the radiologist. High resolution and high frequency ultrasound (12 MHz) with adequate focusing, fine-tunig and grayscale regulation should be ready available in operating room. Machine with low resolution and frequency (8 MHz) with inadequate tuning are not enough to have a good imaging and could be misleading (10) . The patient, before being subjected to this type of approach has to be informed in detail about the various benefits, risks and implications, first of all the possibility of being subjected to a second surgery as soon as the urologist is in possession of the definitive histological result.
CONCLUSION
Testicular sparing surgery of single testicular nodules below 15 mm is a safe option, but requires a standardized pathway in diagnosis. Our pathway has shown good reliability and security profile to be applied in a multicenter management for small scrotal masses. Our study has shown the reliability of the diagnostic-therapeutic pathway in the management of single testicular masses. The higher incidence of benign lesions in 60% of patients makes testis-sparing surgery a reliable option, where orchiectomy could be considered an overtreatment.
